First experience of endoscopic radiofrequency ablation in tumor-induced stenosis of extrahepatic bile ducts

   Aim. To evaluate technical features, safety and efficiency of radiofrequency ablation in tumor strictures of extrahepatic bile ducts.

   Materials and methods. An ongoing prospective observational study from September 2022 to June 2023 enrolled patients with unresectable extrahepatic bile duct tumors. Examination involved esophagogastroduodenoscopy, endoscopic ultrasound, retrograde cholangiopancreatography and video choledochoscopy with biopsy. Ductal
radiofrequency ablation with polymeric or self-expanding metallic stent placement was applied as the main treatment method for the first time in Russia.

   Results. 3 patients (75 %) were diagnosed with cholangiocarcinoma of stage IIb–IIIa, 1 patient – with mucinous cystic tumor with signs of severe intraepithelial neoplasia. Radiofrequency ablation was successfully performed in all patients: tumor stenosis was completely eliminated, no complications reported in the immediate and distant period. The median follow-up period amounted to 8 months.

   Conclusion. The results of the first application of ductal radiofrequency ablation in unresectable tumors of extrahepatic bile ducts with stenosis prove to be positive. The method is considered to be effective, minimally invasive and safe.

1. Ellington T.D., Momin B., Wilson R.J., Henley S.J., Wu M., Ryerson A.B. Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race/ethnicity, and stage at diagnosis: United States, 2013 to 2017. Cancer Epidemiol. Biomarkers Prev. 2021; 30 (9): 1607–1614. doi: 10.1158/1055-9965.EPI-21-0265

2. Flemming J.A., Zhang-Salomons J., Nanji S., Booth C.M. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study. Cancer. 2016; 122 (16): 2534–2543. doi: 10.1002/cncr.30074

3. Pu L.Z., de Moura E.G.H., Bernardo W.M., Baracat F.I., Mendonça E.Q., Kondo A., Luz G.O., Júnior C.K.F., de Almeida Artifon E.L. Endoscopic stenting for inoperable malignant biliary obstruction : a systematic review and metaanalysis. World J. Gastroenterol. 2015; 21 (47): 13374–13385. doi: 10.3748/wjg.v21.i47.13374

4. Tatli S., Tapan Ü., Morrison P.R., Silverman S.G. Radiofrequency ablation: technique and clinical applications. Diagn. Interv. Radiol. 2012; 18 (5): 508–516. doi: 10.4261/1305-3825.DIR.5168-11.1

5. Jarosova J., Macinga P., Hujova A., Kral J., Urban O., Spicak J., Hucl T. Endoscopic radiofrequency ablation for malignant biliary obstruction. World J. Gastrointest. Oncol. 2021; 13 (10): 1383–1396. doi: 10.4251/wjgo.v13.i10.1383

6. Lee Y.N., Jeong S., Choi H.J., Cho J.H., Cheon Y.K., Park S.W., Kim Y.S., Lee D.H., Moon J.H. The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: a prospective multicenter study. J. Gastroenterol. Hepatol. 2019; 34 (8): 1454–1459. doi: 10.1111/jgh.14657

7. Goldberg S.N., Mallery S., Gazelle G.S., Brugge W.R. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest. Endosc. 1999; 50 (3): 392–401. doi: 10.1053/ge.1999.v50.98847

8. Carrara S., Arcidiacono P., Albarello L., Addis A., Enderle M., Boemo C., Campagnol M., Ambrosi A., Doglioni C., Testoni P. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008; 40 (04): 321–326. doi: 10.1055/s-2007-995595

9. Kim H.J., Seo D.-W., Hassanuddin A., Kim S.-H., Chae H.J., Jang J.W., Park D.H., Lee S.S., Lee S.-K., Kim M.-H. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest. Endosc. 2012; 76 (5): 1039–1043. doi: 10.1016/j.gie.2012.07.015

10. Rossi S., Ravetta V., Rosa L., Ghittoni G., Viera F.T., Garbagnati F., Silini E.M., Dionigi P., Calliada F., Quaretti P. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011; 53 (1): 136–147. doi: 10.1002/hep.23965

11. Rossi S., Dore R., Cascina A., Vespro V., Garbagnati F., Rosa L., Ravetta V., Azzaretti A., Di Tolla P., Orlandoni G. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur. Respir. J. 2006; 27 (3): 556–563. doi: 10.1183/09031936.06.00052905

12. Atwell T.D., Schmit G.D., Boorjian S.A., Mandrekar J., Kurup A.N., Weisbrod A.J., Chow G.K., Leibovich B.C., Callstrom M.R., Patterson D.E. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am. J. Roentgenol. 2013; 200 (2): 461–466. doi: 10.2214/AJR.12.8618

13. Mohan H., Nicholson P., Winter D.C., O’Shea D., O’Toole D., Geoghegan J., Maguire D., Hoti E., Traynor O., Cantwell C.P. Radiofrequency ablation for neuroendocrine liver metastases : a systematic review. J. Vasc. Interv. Radiol. 2015; 26 (7): 935–942.e1. doi: 10.1016/j.jvir.2014.12.009

14. Oh D., Chong J., Song T.J., Park D.H., Lee S.S., Seo D.W., Lee S.K., Kim M.H. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction. J. Gastroenterol. Hepatol. 2022; 37 (11): 2083–2090. doi: 10.1111/jgh.15967

15. Kang H., Han S.Y., Cho J.H., Kim E.J., Kim D.U., Yang J.K., Jeon S., Park G., Lee T.H. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: a pilot multicenter randomized comparative trial. J. Hepatobiliary Pancreat. Sci. 2022; 29 (4): 469–478. doi: 10.1002/jhbp.1082

16. Steel A.W., Postgate A.J., Khorsandi S., Nicholls J., Jiao L., Vlavianos P., Habib N., Westaby D. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest. Endosc. 2011; 73 (1): 149–153. doi: 10.1016/j.gie.2010.09.031

17. Laleman W., Van der Merwe S., Verbeke L., Vanbeckevoort D., Aerts R., Prenen H., Van Cutsem E., Verslype C. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy. 2017; 49 (10): 977–982. doi: 10.1055/s-0043-113559

18. Kadayifci A., Atar M., Forcione D.G., Casey B.W., Kelsey P.B., Brugge W.R. Radiofrequency ablation for the management of occluded biliary metal stents. Endoscopy. 2016; 48 (12): 1096–1101. doi: 10.1055/s-0042-115938

19. Nayar M.K., Oppong K.W., Bekkali N.L., Leeds J.S. Novel temperature-controlled RFA probe for treatment of blocked metal biliary stents in patients with pancreaticobiliary cancers: initial experience. Endosc. Int. Open. 2018; 6 (5): E513–E517. doi: 10.1055/s-0044-102097

20. Yoon W.J., Daglilar E.S., Kamionek M., Mino-Kenudson M., Brugge W.R. Evaluation of radiofrequency ablation using a 1-Fr wire electrode in porcine pancreas, liver, gallbladder, spleen, kidney, stomach, and lymph nodes: a pilot study. Dig. Endosc. 2016; 28 (4): 465–468. doi: 10.1111/den.12575

21. Tringali A., Matteo M.V., Orlandini B., Barbaro F., Perri V., Zhang Q., Ricci R., Costamagna G. Radiofrequency ablation for intraductal extension of ampullary adenomatous lesions: proposal for a standardized protocol. Endosc. Int. Open. 2021; 9 (5): E749–E755. doi: 10.1055/a-1387-7880

22. Camus M., Napoléon B., Vienne A., Le Rhun M., Leblanc S., Barret M., Chaussade S., Robin F., Kaddour N., Prat F. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study. Gastrointest. Endosc. 2018; 88 (3): 511–518. doi: 10.1016/j.gie.2018.04.2332

23. Cho S.H., Oh D., Song T.J., Park D.H., Seo D.-W., Lee S.K., Kim M.-H., Lee S.S. Long-term outcomes of endoscopic intraductal radiofrequency ablation for ampullary adenoma with intraductal extension after endoscopic snare papillectomy. Gut Liver. 2023; 17 (4): 638–646. doi: 10.5009/gnl220201

24. Choi Y.H., Yoon S.B., Chang J.H., Lee I.S. The safety of radiofrequency ablation using a novel temperature-controlled probe for the treatment of residual intraductal lesions after endoscopic papillectomy. Gut Liver. 2021; 15 (2): 307–314. doi: 10.5009/gnl20043